REALTOX LABS, LLC
NPI 1235533779
Clinical Medical Laboratory in Reisterstown, MD

NPI Status: Active since October 13, 2014

Contact Information

200 BUSINESS CENTER DR
REISTERSTOWN, MD
ZIP 21136
Phone: (410) 833-3025
Fax: (410) 833-3158

Get Directions Reviews

  • Organization
  • Clinical Medical Laboratory
  • Accepts Insurance
  • CLIA Number: 21D2077230
  • CLIA Cert. Type: Independent
  • CLIA Exp. Date: 05-05-2027

About REALTOX LABS, LLC

This page provides the complete NPI Profile along with additional information for Realtox Labs, Llc, a provider established in Reisterstown, Maryland operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1235533779 assigned on October 2014. The practitioner's primary taxonomy code is 291U00000X with license number 21D2077230 (MD). The provider is registered as an organization and their NPI record was last updated 11 years ago. The authorized official of this NPI record is Mr. Joshua Gochnauer (Owner)

NPI
1235533779
Provider Name
REALTOX LABS, LLC
Entity Type
Organization
Location Address
200 BUSINESS CENTER DR REISTERSTOWN, MD 21136
Location Phone
(410) 833-3025
Location Fax
(410) 833-3158
Mailing Address
200 BUSINESS CENTER DR REISTERSTOWN, MD 21136
Mailing Phone
(410) 833-3025
Mailing Fax
(410) 833-3158
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
10-13-2014
Last Update Date
10-13-2014
Code Navigator

Establishments like Realtox Labs, Llc are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.

Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinical Medical Laboratory

Taxonomy Code
291U00000X
Type
Laboratories
License No.
21D2077230
License State
MD
Taxonomy Description
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.

Insurance Plans Accepted

According to publicly available information the provider might be accepting the following health plans from these health insurance companies:

  • Complete Gold - EPO
  • Complete Gold + Vision + Adult Dental - EPO
  • Complete Silver - EPO
  • Complete Silver + Vision + Adult Dental - EPO
  • Elite Bronze - EPO
  • Elite Bronze + Vision + Adult Dental - EPO
  • Everyday Bronze - EPO
  • Everyday Bronze + Vision + Adult Dental - EPO
  • Everyday Gold - EPO
  • Everyday Gold + Vision + Adult Dental - EPO
  • Clear Silver - HMO
  • Elite Bronze - HMO
  • Elite Bronze + Vision + Adult Dental - HMO
  • Elite Gold - HMO
  • Elite Gold + Vision + Adult Dental - HMO
  • Everyday Bronze - HMO
  • Everyday Bronze + Vision + Adult Dental - HMO
  • Everyday Gold - HMO
  • Everyday Gold + Vision + Adult Dental - HMO
  • Focused Silver - HMO
  • Choice Bronze HSA - HMO
  • Choice Bronze HSA + Vision + Adult Dental - HMO
  • Clear Gold - HMO
  • Clear Gold + Vision + Adult Dental - HMO
  • Clear Silver - HMO
  • Complete Gold - HMO
  • Complete Gold + Vision + Adult Dental - HMO
  • Complete Silver - HMO
  • Complete Silver + Vision + Adult Dental - HMO
  • Elite Bronze - HMO
  • Clear Gold - EPO
  • Clear Gold + Vision + Adult Dental - EPO
  • Complete Gold - EPO
  • Complete Gold + Vision + Adult Dental - EPO
  • Elite Silver - EPO
  • Elite Silver + Vision + Adult Dental - EPO
  • Everyday Bronze - EPO
  • Everyday Bronze + Vision + Adult Dental - EPO
  • Focused Silver - EPO
  • Focused Silver + Vision + Adult Dental - EPO
  • Central Bronze - HMO
  • Central Bronze + Vision + Adult Dental - HMO
  • Central Gold - HMO
  • Central Gold + Vision + Adult Dental - HMO
  • Clear Silver - HMO
  • Everyday Bronze - HMO
  • Everyday Bronze + Vision + Adult Dental - HMO
  • Everyday Gold - HMO
  • Everyday Gold + Vision + Adult Dental - HMO
  • Focused Silver - HMO
  • Blue AdvanceHealth Bronze - Neighborhood Network - HMO
  • Blue AdvanceHealth Gold - Neighborhood Network - HMO
  • Blue AdvanceHealth Silver - Neighborhood Network - HMO
  • Blue EverydayHealth Gold - Neighborhood Network - HMO
  • Blue EverydayHealth Silver - Neighborhood Network - HMO
  • Blue Portfolio HSA Bronze - Neighborhood Network - HMO
  • Blue Portfolio HSA Gold - Statewide PPO Network - PPO
  • Blue PPO PremierHealth Silver - Statewide PPO Network - PPO
  • Blue PPO PremierHealth Gold - Statewide PPO Network - PPO
  • Blue PPO StandardHealth Gold - Statewide PPO Network - PPO
  • Bronze 10 - HMO
  • Bronze 4 - HMO
  • Bronze 8 - HMO
  • Bronze 9 - HMO
  • Gold 1 - HMO
  • Gold 1 with Adult Vision Services - HMO
  • Gold 8 - HMO
  • Gold 8 with Rx Copay - HMO
  • Silver 1 - HMO
  • Silver 1 with Adult Vision Services - HMO

Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.

Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.

*Please verify directly with this provider to make sure your insurance plan is currently accepted.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

MR. JOSHUA GOCHNAUER

Authorized Official Title
OWNER
Authorized Official Phone
(410) 833-3025

Additional Identifiers

The NPI Enumerator encourages providers to submit additional identifiers with their NPI application although the submission of this information is optional. The additional identifier(s) section includes other numbers or codes currently or formerly used as an identifier for the provider by other public healthcare entities. The identifiers may include UPIN, NSC, OSCAR, DEA, Medicaid State or PIN identification numbers.

Identifier Type / Code Identifier State Identifier Issuer
21D2077230OTHER (01)MDCLIA

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Detection of mycoplasma genitalium by dna or rna probe

This procedure involves the use of special probes to identify the presence of a specific bacteria, Mycoplasma Genitalium, in your body. These probes detect the bacteria's unique DNA or RNA, helping to confirm if you have an infection.

This service was performed 151 times for 138 patients

Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b

This test detects the presence of SARS-CoV-2 (COVID-19) and Influenza types A and B in your body. It uses a method called the multiplex amplified probe technique to amplify and identify specific virus genes. It helps in early diagnosis and appropriate treatment.

This service was performed 291 times for 150 patients

Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus

This test identifies if you have COVID-19, influenza A or B, or respiratory syncytial virus. It uses a multiplex amplified probe technique, which amplifies and detects specific genetic material of the viruses, helping in accurate diagnosis.

This service was performed 426 times for 273 patients

Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique

This test checks for the presence of Chlamydia pneumoniae, a bacterium that can cause respiratory infections. It uses an amplified probe technique, which magnifies the bacterium's genetic material for easier detection. It's a standard, non-invasive procedure.

This service was performed 110 times for 106 patients

Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique

A detection test by nucleic acid for chlamydia trachomatis, amplified probe technique, is a test that identifies the presence of a specific bacteria in the body. This bacteria can cause various health issues. The technique amplifies the sample to improve accuracy.

This service was performed 111 times for 105 patients

Detection test by nucleic acid for chlamydia trachomatis, quantification

A detection test by nucleic acid for Chlamydia trachomatis is a procedure to identify a common bacteria in your body. This is done by examining samples taken from your body. The test measures the quantity of bacteria present, which helps in determining the best treatment.

This service was performed 105 times for 97 patients

Detection test by nucleic acid for cytomegalovirus, quantification

A nucleic acid test for cytomegalovirus (CMV) is a diagnostic tool used to measure the amount of CMV in your body. CMV is a common virus that can cause various symptoms. This test helps to monitor and manage the virus effectively.

This service was performed 2,986 times for 2,342 patients

Detection test by nucleic acid for herpes simplex virus, amplified probe technique

This test uses an amplified probe technique to identify the presence of the herpes simplex virus in your body. It works by detecting the virus's genetic material, or nucleic acid. The test is accurate, reliable, and can help in early detection and treatment.

This service was performed 30 times for 28 patients

Detection test by nucleic acid for herpes simplex virus, quantification

This test identifies the presence of the herpes simplex virus (HSV) in your body through a sample, often a swab from a sore or blood. It uses nucleic acid technology to measure the amount of virus, helping to monitor the infection's progression and response to treatment.

This service was performed 210 times for 97 patients

Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique

This test checks for Mycoplasma pneumoniae, a bacteria that can cause lung infection. It uses a method called amplified probe technique, which identifies the bacteria's genetic material. This helps in diagnosing the infection accurately.

This service was performed 110 times for 106 patients

Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique

This is a lab test that checks for the presence of a specific bacteria called Neisseria gonorrhoeae in your body. It uses a technique called amplified probe, which makes many copies of the bacteria's genetic material (nucleic acid) to help detect it more easily.

This service was performed 111 times for 105 patients

Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), quantification

This is a lab test that identifies and measures the amount of Neisseria gonorrhoeae bacteria, which can cause certain infections, in your body. It uses a method called nucleic acid detection to find this bacteria's genetic material in a sample taken from your body.

This service was performed 105 times for 97 patients

Detection test by nucleic acid for organism, amplified probe technique

A nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.

This service was performed 51,213 times for 4,447 patients

Detection test by nucleic acid for organism, quantification

A detection test by nucleic acid quantification is a lab procedure used to identify specific organisms in your body. It measures the amount of an organism's genetic material, helping to diagnose and monitor certain diseases.

This service was performed 8,805 times for 2,303 patients

Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique

A detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.

This service was performed 6,431 times for 4,417 patients

Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique

This test detects Group A Streptococcus bacteria in your body. It uses an amplified probe technique, which amplifies the bacteria's nucleic acid, making it easier to identify. This test helps diagnose conditions like strep throat or scarlet fever.

This service was performed 3,435 times for 2,569 patients

Detection test by nucleic acid for strep (streptococcus, group a), quantification

A detection test by nucleic acid for Group A Strep is a diagnostic procedure that identifies the presence and quantity of streptococcus bacteria in your body. This test uses a sample, usually a throat swab, to detect the bacteria's genetic material. It helps in diagnosing infections like strep throat.

This service was performed 2,966 times for 2,327 patients

Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique

A detection test by nucleic acid for Group B Strep uses an amplified probe technique. This test identifies the presence of Group B Strep bacteria in the body. It involves collecting a sample, usually a swab, which is then examined in a lab for the bacteria's genetic material.

This service was performed 6,434 times for 4,418 patients

Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique

This is a test to identify a common microscopic organism that can cause discomfort. The technique involves using a special probe to amplify the organism's genetic material, making it easier to detect. It's a simple, safe, and accurate procedure.

This service was performed 106 times for 99 patients

Detection test for candida species (yeast), amplified probe technique

This test helps identify Candida, a type of fungus often present in the human body. An amplified probe technique is used, which enhances detection of the fungus in a sample. This method increases the accuracy of the test, helping to determine the best treatment.

This service was performed 19,922 times for 4,401 patients

Detection test for candida species (yeast), quantification

A detection test for Candida species quantifies the amount of yeast in your body. This test involves collecting a sample from the concerned area, which is then examined in a lab. It helps in diagnosing yeast infections and guiding treatment plans.

This service was performed 2,963 times for 2,325 patients

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test is a detailed analysis used to identify specific drugs in your system. It uses advanced techniques, such as gc/ms and lc/ms, to detect and distinguish between different drugs, even those with similar structures.

This service was performed 134 times for 92 patients

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test identifies specific drugs in your system. Advanced methods like GC/MS (Gas Chromatography/Mass Spectrometry) and LC/MS (Liquid Chromatography/Mass Spectrometry) are used. These can distinguish between similar drugs, providing precise results.

This service was performed 1,264 times for 655 patients

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test identifies specific drugs in your system. It uses advanced methods like gc/ms and lc/ms, which can distinguish between different types of drugs but not necessarily their 3D forms. This test offers detailed results to support your healthcare decisions.

This service was performed 1,766 times for 608 patients

Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution

This process checks how well certain drugs, like antibiotics, can fight against infections. It involves mixing the drug with a microbe (like bacteria or a virus) in a lab. By observing how the microbe reacts, it helps determine the best drug to treat your infection.

This service was performed 8,972 times for 1,842 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within

This is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.

This service was performed 32,030 times for 2,940 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r

This is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.

This service was performed 32,528 times for 3,023 patients

Measurement of dna of bacteria in vaginal fluid specimen

This procedure involves analyzing a sample from the female body to measure the amount of bacterial DNA present. It is a common method used to assess the balance of microorganisms, which is crucial for maintaining good health. It's a simple, non-invasive test.

This service was performed 46 times for 40 patients

Testing for presence of drug, by chemistry analyzers

Chemistry analyzers are used to detect the presence of drugs in your system. This test involves taking a small sample of your blood or urine. The sample is then analyzed for specific substances. The results help in understanding your health condition better.

This service was performed 38 times for 28 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
21D2077230
Facility Type
Independent
Certificate Effective Date
May 06, 2025
Certificate Expiration Date
May 05, 2027
Laboratory Director
DR. YOCHAN JEONG
Certificate Type
Certificate of Accreditation
Certificate Type Description
This is a CLIA certificate is issued to Realtox Labs, Llc on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.

Reviews for REALTOX LABS, LLC

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI Validation Check Digit Calculation


The following table explains the step by step NPI number validation process using the ISO standard Luhn algorithm.

Start with the original NPI number, the last digit is the check digit and is not used in the calculation.
1235533779
Step 1: Double the value of the alternate digits, beginning with the rightmost digit.
22651036714
Step 2: Add all the doubled and unaffected individual digits from step 1 plus the constant number 24.
2 + 2 + 6 + 5 + 1 + 0 + 3 + 6 + 7 + 1 + 4 + 24 = 61
Step 3: Subtract the total obtained in step 2 from the next higher number ending in zero, the result is the check digit.
70 - 61 = 99

The NPI number 1235533779 is valid because the calculated check digit 9 using the Luhn validation algorithm matches the last digit of the original NPI number.

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1235533779, enumerated in the NPI registry as an "organization" on October 13, 2014

The provider is located at 200 Business Center Dr Reisterstown, Md 21136 and the phone number is (410) 833-3025

This medical organization specializes in Clinical Medical Laboratory with taxonomy code 291U00000X

The provider might be accepting Accepts: Ambetter from Home State Health, Ambetter from. Please consult your insurance carrier or call the provider to make sure your health plan is currently accepted.

The most common procedures or services performed by this practitioner are: Detection of mycoplasma genitalium by dna or rna probe, Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b, Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus, Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique, Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique, Detection test by nucleic acid for chlamydia trachomatis, quantification, Detection test by nucleic acid for cytomegalovirus, quantification, Detection test by nucleic acid for herpes simplex virus, amplified probe technique, Detection test by nucleic acid for herpes simplex virus, quantification, Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique, Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique, Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), quantification, Detection test by nucleic acid for organism, amplified probe technique, Detection test by nucleic acid for organism, quantification, Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique, Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique, Detection test by nucleic acid for strep (streptococcus, group a), quantification, Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique, Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique, Detection test for candida species (yeast), amplified probe technique, Detection test for candida species (yeast), quantification, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms, Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r, Measurement of dna of bacteria in vaginal fluid specimen and Testing for presence of drug, by chemistry analyzers.

The provider's CLIA number is 21D2077230 for a "independent" facility with a CLIA Certificate of Accreditation. This is a CLIA certificate is issued on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing..

This NPI record was last updated on October 13, 2014. To officially update your NPI information contact the National Plan and Provider Enumeration System (NPPES) at 1-800-465-3203 (NPI Toll-Free) or by email at [email protected].
NPI Profile data is regularly updated with the latest NPI registry information, if you would like to update or remove your NPI Profile in this website please contact us.